Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
REVIVA PHARMACEUTICALS HOLDINGS, INC. shareholders approved Election of each of Laxminarayan Bhat, Parag Saxena, Richard Margolin, Purav Patel and Les Funtleyder as directors at the 2022-11-10 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2022-11-10
Exact text from the filing
1. The election of each of Laxminarayan Bhat, Parag Saxena, Richard Margolin, Purav Patel and Les Funtleyder as directors to hold office for a term of one year, until their successor is duly elected and qualified or they are otherwise unable to complete their term. The votes were cast for this matter as follows: Votes Broker Non- Nominees Votes For Withheld Votes Laxminarayan Bhat 8,305,931 10,834 4,702,220 Parag Saxena 7,787,682 529,083 4,702,220 Richard Margolin 8,306,224 10,541 4,702,220 Purav Patel 8,296,697 20,068 4,702,220 Les Funtleyder 8,306,214 10,551 4,702,220
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
REVIVA PHARMACEUTICALS HOLDINGS, INC. shareholders approved Ratification of the appointment of Armanino LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022 at the 2022-11-10 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2022-11-10
Exact text from the filing
2. The proposal to ratify the appointment of Armanino LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2022 was approved based upon the following votes: Votes For Votes Against Abstentions Broker Non-Votes 12,986,442 11,054 21,489 0
View on SEC.gov